Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018.
The Company’s self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration (“NMPA”) and commercialized in China.
Company’s Keywords:
39
medical devices
65247000
DNS.com, reCAPTCHA, Mobile Friendly, Google Maps, Google Maps (Non Paid Users), Apache, JQuery 1.11.1
2009